Evaluation of the impact of atrial fibrillation on rehospitalization events in heart failure patients in recent years

Journal of Cardiology

Volumn 60, Issue 1, 2012, Pages 36-41

  Murakami, Masami ^a   Niwano, Shinichi ^a   Koitabashi, Toshimi ^a   Inomata, Takayuki ^a   Satoh, Akira ^a   Kishihara, Jun ^a   Ishikawa, Shoko ^a   Aoyama, Yuya ^a   Niwano, Hiroe ^a   Izumi, Tohru ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Atrial fibrillation; Heart failure; Risk factors

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

AGED; ARTICLE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CHRONIC DISEASE; CLINICAL EVALUATION; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART RHYTHM; HOSPITAL ADMISSION; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PAROXYSMAL HEART ATRIUM FIBRILLATION; PROGNOSIS; RETROSPECTIVE STUDY; SINUS RHYTHM;

ADRENERGIC BETA-ANTAGONISTS; AGED; ATRIAL FIBRILLATION; FEMALE; HEART FAILURE; HUMANS; MALE; PATIENT READMISSION; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84864035432     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2012.01.020     Document Type: Article

References (26)

1. Kannel W.B., Abbott R.D., Savage D.D., McNamara P.M. Coronary heart disease and atrial fibrillation: The Framingham Study. Am Heart J 1983, 106:389-396.
2. Go A.S., Hylek E.M., Phillips K.A., Chang Y., Henault L.E., Selby J.V., Singer D.E. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. JAMA 2001, 285:2370-2375.
3. Wojtkowska I., Sobkowicz B., Musiat W.J., Kozuch M. Persistent atrial fibrillation as prognostic factor of outcome in patients with advanced heart failure. Kardiol Pol 2006, 64:777-783.
4. Suzuki S., Yamashita T., Otsuka T., Sagara K., Uejima T., Oikawa Y., Yajima J., Koike A., Nagashima K., Kirigaya H., Ogasawara K., Sawada H., Aizawa T. Recent mortality of Japanese patients with atrial fibrillation in an urban city of Tokyo. J Cardiol 2011, 58:116-123.
5. Carson P.E., Johnson G.R., Dunkman W.B., Fletcher R.D., Farrell L., Chon J.N. The influence of atrial fibrillation on prognosis in mild to moderate heart failure: the V-HeFT studies: the V-HeFT VA cooperative studies group. Circulation 1993, 87(Suppl. VI):VI102-VI110.
6. The AFFIRM Investigators Baseline characteristics of patients with atrial fibrillation: AFFIRM Study. Am Heart J 2002, 143:991-1001.
7. Naito M., David D., Michelson E.L., Schaffenburg M., Dreifus L.S. The hemodynamic consequences of cardiac arrhythmia: evaluation of the relative roles of abnormal atrioventricular sequencing, irregularity of ventricular rhythm and atrial fibrillation in a canine model. Am Heart J 1983, 106:284-291.
8. Dries D.L., Exner D.V., Gersh B.J., Domanski M.J., Waclawiw M.A., Stevenson L.W. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. JACC 1998, 32:695-703.
9. Olsson L.G., Swedberg K., Ducharme A., Granger C.B., Michelson E.L., McMurray J.J.V., Puu M., Yusuf S., Pfeffer M.A. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction. JACC 2006, 47:1997-2004.
10. Roy D., Talajic M., Nattel S., Wyse D.G., Dorian P., Lee K.L., Bourassa M.G., Arnold M.O., Buxton A.E., Camm A.J., Connolly S.J., Cubuc M., Ducharme A., Guerra P.G., Hohnloser S.H., et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Eng J Med 2008, 358:2667-2677.
11. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators A comparison of rate control and rhythm control in patients with atrial fibrillation. N Eng J Med 2002, 347:1825-1833.
12. Hamaguchi S., Yokoshiki H., Kinugawa S., Tsuchihashi-Makaya M., Yokota T., Takeshita A., Tsutsui H. Effects of atrial fibrillation on long-term outcomes in patients hospitalized for heart failure in Japan - A Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD). Circ J 2009, 73:2084-2090.
13. Tsutsui H., Tsuchihashi-Makaya M., Kinugawa S. Clinical characteristics and outcomes of heart failure with preserved ejection fraction: lessons from epidemiological studies. J Cardiol 2010, 55:13-22.
14. Koitabashi T., Inomata T., Niwano S., Nishii M., Takeuchi I., Nakano H., Shinagawa H., Takehana H., Izumi T. Paroxysmal atrial fibrillation coincident with cardiac decompensation is a predictor of poor prognosis in chronic heart failure. Circ J 2005, 69:823-830.
15. Tohru I., Kazuyuki O. Clinical characteristics of chronic congestive heart failure patients with atrial fibrillation. Therap Res 2000, 21:501-507. (in Japanese).
16. Camm A.J., Kirchhof P., Lip G.Y.H., Schotten U., Savelieva I., Ernst S., Gelder I.C.V., Al-Attar N., Hindricks G., Prendergast B., Heidbuchel H., Alfieri O., Angelini A., Atar D., Colonna P., et al. Guidelines for the management of atrial fibrillation. The task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010, 31:2369-2429.
17. Hess G., Preblick R., Hill J., Plauschinat C.A., Yaskin J. Effects of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy after hospital discharge on subsequent rehospitalization for acute myocardial infarction and heart failure. Congest Heart Fail 2009, 15:170-175.
18. Middlekauff H.R., Stevenson W.G., Stevenson L.W. Prognostic significance of atrial fibrillation in advanced heart failure. Circulation 1991, 84:40-48.
19. Francis G.S., Benedict C., Johnstone D.E., Kirlin P.C., Nicklas J., Liang C.S., Kubo S.H., Rubin-Toretsky E., Yusuf S. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substudy of the studies of left ventricular dysfunction (SOVLD). Circulation 1990, 82:1724-1729.
20. Komukai K., Yagi H., Ogawa T., Date T., Morimoto S., Kawai M., Hongo K., Taniguchi I., Yoshimura M. Inhibition of the renin-angiotensin system prevents re-hospitalization of heart failure patients with preserved ejection fraction. Circ J 2008, 72:2004-2008.
21. Koitabashi T., Inomata T., Niwano S., Nishii M., Takeuchi I., Nakano H., Shinagawa H., Takehana H., Izumi T. Distinguishable optimal levels of plasma B-type natriuretic peptide in heart failure management based on complicated atrial fibrillation. Int Heart J 2005, 46:453-464.
22. Gakowski A., Isnard R., Golmard J.L., Pousset F., Carayon A., Montalescot G., Hulot J.S., Thomas D., Piwowarska W., Komajda M. Comparison of echocardiography and plasma B-type natriuretic peptide for monitoring the response to treatment in acute heart failure. Eur Heart J 2004, 25:1788-1796.
23. Kubler P., Petruk-Kowalczyk J., Majda J., Reczuch K., Banasiak W., Ponikowski P. Persistent high NTpro-BNP concentration as a negative prognostic factor in patients with decompensated heart failure. Kardiol Pol 2006, 64:250-256.
24. Szyguta-Jurkiewicz B., Owczarek A., Duszanska A., Sikora J., Lekston A., Pudlo R., Wojnicz R., Polonski L. Long-term prognosis and risk factors for cardiac adverse events in patients with chronic systolic heart failure due to hypertension. Pol Arch Med Wewn 2008, 118:280-287.
25. Komukai K., Ogawa T., Yagi H., Date T., Sakamoto H., Kanzaki Y., Shibayama K., Hashimoto K., Inada K., Minami K., Ogawa K., Kosuga T., Kawai M., Hongo K., Taniguchi I., et al. Decreased renal function as independent predictor of re-hospitalization for congestive heart failure. Circ J 2008, 72:1152-1157.
26. Matsushita K., Muramatsu T., Kondo T., Maeda K., Shintani S., Murohara T. Rationale and design of the NAGOYA HEART Study: comparison between valsartan and amlodipine regarding morbidity and mortality in patients with hypertension and glucose intolerance. J Cardiol 2010, 56:111-117. NAGOYA HEART Study Group.